Skip to main content
ELV logo

ELV · Elevance Health, Inc. · Executive Compensation

Track ELV — free
$439.95 -5.33 (-1.20%) At close · Oct 23
Market Cap
$95.05B
Shares
216.06M
Volume · Oct 23 1.17M Avg daily vol (3M) 1.15M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Gail Boudreaux $22,582,314
Mark Kaye $7,992,077
Peter D. Haytaian $7,098,488
Felicia Norwood $7,073,965
Morgan Kendrick $6,661,911
Fiscal 2024
Executive Total
Gail Boudreaux $20,471,976
Mark Kaye $6,873,144
Peter D. Haytaian $6,345,127
Felicia Norwood $6,288,946
Morgan Kendrick $5,793,474
Fiscal 2023
Executive Total
Gail Boudreaux $21,889,039
Mark Kaye $14,859,201
Mark B. Kaye $12,359,201
John Gallina $8,165,416
Blair Todt $8,112,972
Peter D. Haytaian $6,978,051
Felicia Norwood $6,475,408
Fiscal 2022
Executive Total
Gail Boudreaux $20,931,081
John Gallina $7,641,837
Gloria M. McCarthy $6,426,376
Peter D. Haytaian $6,387,729
Felicia Norwood $6,386,987
Fiscal 2021
Executive Total
Gail Boudreaux $19,348,241
Peter D. Haytaian $7,888,858
John Gallina $6,141,280
Gloria M. McCarthy $5,923,134
Felicia Norwood $5,833,937
Fiscal 2020
Executive Total
Gail Boudreaux $17,109,952
Gloria M. McCarthy $5,530,661
John Gallina $5,401,735
Peter D. Haytaian $5,387,111
Felicia Norwood $5,236,403
Fiscal 2019
Executive Total
Gail Boudreaux $15,473,139
Felicia Norwood $7,922,755
Gloria M. McCarthy $5,247,126
John Gallina $5,109,053
Peter D. Haytaian $5,076,966
Fiscal 2018
Executive Total
Gail Boudreaux $14,184,276
Peter D. Haytaian $5,936,543
Gloria M. McCarthy $5,436,787
John Gallina $5,153,866
Fiscal 2017
Executive Total
Gloria M. McCarthy $5,816,686
John Gallina $5,478,983
Peter D. Haytaian $5,422,957
Gail Boudreaux $2,166,253

Executive changes

Person Change Filed
Amy W. Schulman Appointed 2025-12-10
Steven H. Collis Appointed 2025-07-28
Mark Kaye Appointed 2023-08-08
Gloria M. McCarthy Appointed 2023-02-22
Deanna Strable-Soethout Appointed 2022-10-25

Leadership

Key facts CIK 1156039 CUSIP 036752103 13F (30d) 429 filings 405 filers Visit website Investor relations